SCRIPT – Research on sale of cannabis in pharmacies

The main aim of this pilot trial is to evaluate what impact a regulated not-for-profit sale of cannabis in pharmacies combined with related advisory services may have on cannabis consumption.

Any shift from smoking to other forms of cannabis consumption will be of particular interest. One study group will be able to obtain cannabis products from the outset, while a second group will be able to do so after six months. The trial will then run for a further 18 months.

Responsible organisation(s)

Implementing institutions

• University of Bern: 
  
  • Institute of Primary Health Care, Substance Consumption Unit (BIHAM)
  • Clinical Trial Unit (CTU)
  • Institut für Sozial- und Präventivmedizin (ISPM)
  • Universitäre Psychiatrische Dienste Bern (UPD)
• Universität Luzern:
  • Zentrum für Hausarztmedizin und Community Care

 

Person for contact

• Prof. Dr. med. Reto Auer
  Universität Bern
  Head of Substance Consumption
  Mittelstrasse 43
  3012 Bern
  [e-mail]
  [phone]

Canton(s)

Cantons of Bern and Lucern

Municipality

Bern, Biel and Lucern

Planned duration of the study

from october 2023 until april 2026

Points of sale

Pharmacies

Study type

• Randomised controlled trial (RCT)
  
  

Sample size

Experimental group n1 = 546
Control group n4 = 546
Total sample size N = 1'091

Funder

• Swiss National Science Foundation (SNF)
  
• Tobacco Control Fund (TCF)
• the participating cities

Links

• www.script-studie.ch

Last modification 20.10.2023